SCHEMBL2494922

SCHEMBL2494922

[CH2]c1cccc(-c2ccccc2CCCC)c1-c1ccccc1CCCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
ELANE P08246 4/20 0.38
CTSG P08311 4/20 0.38
LIPG Q9Y5X9 1/20 0.38
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX5 P09917 1/20 0.34
PTGS2 P35354 1/20 0.34
TLR8 Q9NR97 1/20 0.33
CNR2 P34972 1/20 0.33
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33
BID P55957 3/20 0.33
MCL1 Q07820 3/20 0.33
BCL2L1 Q07817 2/20 0.33
BAK1 Q16611 2/20 0.33
KAT8 Q9H7Z6 2/20 0.33
PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11416678 0.94 LIPG (0.46) NR1H2NR1H3ELANECTSGLIPG
SCHEMBL2494391 0.90 ELANE (0.35) NR1H2NR1H3ELANECTSGPPARA
SCHEMBL2492797 0.86 LIPG (0.42) NR1H2NR1H3ELANECTSGLIPG
SCHEMBL2488722 0.82 CSNK2A2 (0.39) CYP2D6
SCHEMBL5615323 0.82 ALOX5 (0.43) NR1H2NR1H3ELANECTSGLIPG
SCHEMBL2701240 0.82 LIPG (0.50) NR1H2NR1H3ELANECTSGLIPG
SCHEMBL15656901 0.81 NR1H2 (0.39) NR1H2NR1H3ELANECTSGLIPG
SCHEMBL28357289 0.80 ELANE (0.54) ELANECTSGLIPGALOX5PTGS2
SCHEMBL8674994 0.79 LIPG (0.42) NR1H2NR1H3ELANECTSGLIPG
SCHEMBL392416 0.78 LIPG (0.47) NR1H2NR1H3LIPGCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH NR1H2 3272/4885NR1H3 2833/4885ELANE 814/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 NR1H2 3053/4885NR1H3 2569/4885ELANE 1024/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R NR1H2 2980/4885NR1H3 2510/4885ELANE 873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.